Hepatic involvement in the course of acquired toxoplasmosis.
D000906:Antibodies / Q000032:analysis; D002675:Child, Preschool; D004802:Eosinophilia / Q000150:complications; D005260:Female; D006529:Hepatomegaly / Q000150:complications*; D006801:Humans; D007933:Leucomycins / Q000627:therapeutic use; D008198:Lymph Nodes / Q000503:physiopathology; D011739:Pyrimethamine / Q000627:therapeutic use; D013163:Splenomegaly / Q000150:complications; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology
D000906:Antibodies; D007933:Leucomycins; D013421:Sulfamethoxypyridazine; D011739:Pyrimethamine